The effect of infliximab on inflammation & bone formation biomarkers: Associations with clinical response in ankylosing spondylitis & psoriatic arthritis

被引：0
|
作者：
Visvanathan, S. [1 ]
Marano, C. [1 ]
Braun, J. [2 ]
Kavanaugh, A. [3 ]
Gathany, T. [1 ]
Xu, S. [1 ]
Han, J. [1 ]
Baker, D. [1 ]
Wagner, C.
机构：
[1] Centocor R&D Inc, Malvern, PA USA
[2] Rheum Ruhrgebiet, Herne, Germany
[3] UCSD, Div Rheumatol Allergy & Immunol, La Jolla, CA USA
来源：
RHEUMATOLOGY | 2008年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：II80 / II80
页数：1
相关论文
共 50 条
  • [1] The effect of infliximab on inflammation and bone formation biomarkers and associations with clinical response in ankylosing spondylitis and psoriatic arthritis
    Visvanathan, S.
    Marano, C.
    Braun, J.
    Kavanaugh, A.
    Gathany, T.
    Xu, S.
    Han, J.
    Baker, D.
    Wagner, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 413 - 413
  • [2] Comparison of the effect of infliximab on inflammation and bone formation biomarkers and associations with clinical response in ankylosing spondylitis and psoriatic arthritis.
    Visvanathan, S.
    Marano, C.
    Braun, J.
    Kavanaugh, A.
    Yan, S.
    Gathany, T.
    Han, J.
    Zhou, B.
    Baker, D.
    Wagner, C.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S792 - S792
  • [3] Modulation of biomarkers of inflammation and bone turnover and associations with bone mineral density in ankylosing spondylitis (AS) patients treated with infliximab
    Visvanathan, S.
    Deodhar, A.
    Braun, J.
    Van der Heijde, D.
    Yan, S.
    Gathany, T.
    Geusens, P.
    Williamson, P.
    Wagner, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 547 - 547
  • [4] INFLAMMATION AND BONE FORMATION IN ANKYLOSING SPONDYLITIS
    Thomas, G.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S504 - S504
  • [5] Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
    Visvanathan, S.
    van der Heijde, D.
    Deodhar, A.
    Wagner, C.
    Baker, D. G.
    Han, J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (02) : 175 - 182
  • [6] Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation
    de Vries, Mirjam K.
    Wolbink, Gerrit Jan
    Stapel, Steven O.
    de Vrieze, Henk
    van denderen, J. Christiaan
    Dijkmans, Ben A. C.
    Aarden, Lucien A.
    van der Horst-Bruinsma, Irene E.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) : 1252 - 1254
  • [7] Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation
    Grisar, J
    Bernecker, PM
    Aringer, M
    Redlich, K
    Sedlak, M
    Wolozcszuk, W
    Spitzauer, S
    Grampp, S
    Kainberger, F
    Ebner, W
    Smolen, JS
    Pietschmann, P
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (07) : 1430 - 1436
  • [8] Decreased clinical response to infliximab in ankylosing spondylitis (AS) is significantly correlated with antibody formation
    de Vries, M. K.
    Wolbink, G. J.
    Stapel, S. O.
    de Vrieze, H.
    van denderen, J. C.
    Dijkmans, B. A. C.
    Aarden, L. A.
    van der Horst-Bruinsma, I. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 394 - 395
  • [9] Biosimilar Infliximab Treated-Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in France: Characteristics and Clinical Outcomes
    Marotte, Hubert
    Mammar, Nadir
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [10] Clinical predictors of response to treatment with infliximab in ankylosing spondylitis (AS).
    Stone, M
    Salonen, D
    Payne, U
    Lax, M
    Lapp, V
    Inman, R
    ARTHRITIS AND RHEUMATISM, 2000, 43 (12): : 2857 - 2857
12345